{"schema_version":"secwatch.filing_event.v1","accession":"0001077183-21-000190","form_type":"8-K/A","ticker":"NEO","cik":"0001077183","company_name":"NEOGENOMICS INC","filed_at":"2021-07-15T23:59:59+00:00","discovered_at":"2026-05-14T18:04:17.078456+00:00","generated_at":"2026-06-30T04:59:04.735502+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"NeoGenomics discloses compensation details for Clive Morris as President of Inivata subsidiary","bullets":["Base salary of £405,000 per year; eligible for annual performance bonus targeted at 50% of base salary.","Retention cash bonus of £607,500, 50% payable June 30, 2022 if employed, remainder per agreement.","Equity award valued at $1.4M: 10,708 RSUs (4-year vest) and option for 53,857 shares (7-year term, 4-year vest).","Cash payment of $100,000 within 30 days of Inivata acquisition close.","Subject to non-competition and non-solicitation covenants; participates in Inivata pension scheme."],"urls":{"canonical":"https://secwatch.observer/filing/0001077183-21-000190","json":"https://secwatch.observer/filing/0001077183-21-000190.json","markdown":"https://secwatch.observer/filing/0001077183-21-000190.md","text":"https://secwatch.observer/filing/0001077183-21-000190.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1077183/000107718321000190/0001077183-21-000190-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1077183/000107718321000190/neo-20210618.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T04:59:04.735502+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"61bb611d55","claim":"Clive Morris was appointed as President of Inivata at NEOGENOMICS INC.","evidence_excerpt":"in connection with Mr. Morris’s appointment as President of Inivata.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718321000190/0001077183-21-000190-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President of Inivata"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}